Biotech / Medical
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
448 38 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five ongoing clinical development programs, including four from its PharmacoSurgery™ platform and one from its Addiction program, the most advanced of which is in Phase 3 clinical trials. Omeros may also have the near-term capability, through its GPCR (G-protein coupled receptor) program, to add an unprecedented number of wholly new drug targets to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of antibody and small-molecule preclinical programs targeting inflammation and central nervous system disorders.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
448 Omeros' OMIDRIA Eye Drop OK'ed For Pediatric Use Wong-Wednesday
447Press Release Omeros Corporation to Announce Third Quarter 2017 Financial ResulBiotech Jim-November 6
446Was curious about sales of Omridia. In the area I reside, it does not seem to beD.Lu-November 6
445Bloomberg has this to say last week for products coming up for Pass Through StatBiotech Jim1November 5
444I just saw on Twitter that AF is now saying Omridia will lose Medicare pass-thoutuck-November 3
443Deleted Mistaken PostBulbaMan-September 26
442On watch for clear above 21.59. [graphic]hollyhunter-September 20
441OMER responds to AF, a one time event? Some )MS 721 trials info updated here. Biotech Jim-August 23
440A bit different. Prices at 22.75, and asks pop up below that. Decent pricing, scaram(o)uche-August 15
439Omeros to Present at the 2017 Wedbush PacGrow Healthcare Conference SEATTLE--(BUHoward Williams-August 10
438 OMER short volume volumebot.comJulius Wong1August 9
437Saw the news when it hit and yawned. Now up better than 10%. Own some, have vescaram(o)uche-August 4
436OMER treatment of immunoglobulin A nephropathy granted FDA orphan status theflBiotech Jim1August 4
435Omeros Corporation to Announce Second Quarter 2017 Financial Results on August 8Howard Williams-August 2
434>>That's funny on speculation Martin could be Doyle or affiliated. I dBiomaven-July 25
433I realized this after thinking about it. I was in irrational exuberance territoBiotech Jim-July 25
432Just catching up with this thread. The S-8 is routine - that's what is fileBiomaven1July 24
430That's funny on speculation Martin could be Doyle or affiliated. I doubt it rkrw-July 6
429 It’s been speculated that Art Doyle is Martin Shkreli. For example, this SA posBulbaMan-July 6
428He? Art Doyle as in Sir Arthur Doyle? I assume it could be some hedge fund tharkrw1July 6
427 Bullish Oneil Trader Omeros article on Seeking Alpha posted today. It mentions BulbaMan-July 6
426I thought it was originally 3 parts now up to 6. I guess he'll look for a pughmm-July 6
425FWIW on that. twitter.comrkrw-July 6
424Potential OMS 721 competition, parking this Chemocentryx PR here. Original can Biotech Jim-July 6
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.